Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent
    1.
    发明申请
    Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent 审中-公开
    生产包含微晶剂固体分散体的剂型

    公开(公告)号:US20090012184A1

    公开(公告)日:2009-01-08

    申请号:US11884164

    申请日:2006-02-09

    IPC分类号: A61K47/30

    CPC分类号: A61K9/146 A61K9/145

    摘要: A method is described for the production of dosage forms, which comprise a solid dispersion of a microcrystalline active substance, in which a thermoplastic polymer with a glass transition temperature Tg of at least 40° C. is melted and an active substance is dissolved homogeneously in the melt; crystallization of the active substance is initiated in the mass obtained; and the mass is cooled. Crystallization of the active substance can be initiated by adding a nonsolvent, seed crystals of the active substance or a derivatization reagent. In addition, crystallization can be initiated by holding the mass for a sufficient length of time at a temperature that is below the temperature at which the active substance is completely soluble in the mass.

    摘要翻译: 描述了用于制备剂型的方法,其包含微晶活性物质的固体分散体,其中玻璃化转变温度Tg至少为40℃的热塑性聚合物熔融并将活性物质均匀地溶解在 熔化; 活性物质的结晶在得到的团块中开始; 并且质量被冷却。 活性物质的结晶可以通过加入非溶剂,活性物质的晶种或衍生试剂来引发。 此外,可以通过在低于活性物质完全溶解于物质中的温度的温度下保持质量足够长的时间来引发结晶。

    Antibodies that bind peptides from the hPTH sequence (1-37)
    2.
    发明授权
    Antibodies that bind peptides from the hPTH sequence (1-37) 失效
    从hPTH序列(1-37)结合肽的抗体

    公开(公告)号:US6030790A

    公开(公告)日:2000-02-29

    申请号:US817547

    申请日:1997-03-27

    CPC分类号: C07K14/635 A61K39/00

    摘要: The present invention is directed to peptides from the sequence of hPTH(1-37), which contain .alpha.-helical amino acid sequence regions and/or non-structured amino acid sequence regions, said peptides being capable of inducing antibodies when injected into animals. Furthermore, the invention is directed to a diagnostic agent and antibodies obtainable by immunizing animals using the peptides according to the invention.

    摘要翻译: PCT No.PCT / EP95 / 03757 371日期1997年3月27日 102(e)1997年3月27日PCT PCT 1995年9月22日PCT公布。 WO96 / 10041 PCT出版物 日期1996年4月4日本发明涉及来自含有α-螺旋氨基酸序列区和/或非结构化氨基酸序列区的hPTH(1-37)序列的肽,所述肽能够诱导抗体 注射入动物时。 此外,本发明涉及诊断试剂和通过使用根据本发明的肽免疫动物而获得的抗体。

    Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
    3.
    发明授权
    Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier 有权
    使用交联的非热塑性载体制备固体盖仑制剂的方法

    公开(公告)号:US07846477B2

    公开(公告)日:2010-12-07

    申请号:US10530483

    申请日:2003-10-09

    IPC分类号: A61K9/20 B27N3/00

    摘要: The invention concerns a method for producing solid galenic formulations which consists in: forming a processable paste comprising a) 50 to 99.4 wt. % of at least one non-thermoplastic carrier, b) 0.5 to 30 wt. % of at least an adjuvant selected among thermoplastic polymers, lipids, sugar alcohols and solubilizing agents, c) 0.1 to 49.5 wt. % of at least one active principle, at a temperature not less than the softening temperature of the adjuvant but rising to at least 70° C.; then in cooling the resulting paste. Said solid galenic formulations quickly disintegrate in an aqueous medium.

    摘要翻译: 本发明涉及一种制备固体盖仑制剂的方法,其中包括:形成可加工的糊剂,其包含a)50至99.4wt。 %的至少一种非热塑性载体,b)0.5〜30wt。 至少选自热塑性聚合物,脂质,糖醇和增溶剂中的佐剂的%,c)0.1至49.5wt。 %的至少一种活性成分,在不低于佐剂的软化温度但升至至少70℃的温度下。 然后冷却所得糊状物。 所述固体盖仑制剂在水性介质中快速崩解。

    Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
    4.
    发明申请
    Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier 有权
    使用交联的非热塑性载体制备固体盖仑制剂的方法

    公开(公告)号:US20060257470A1

    公开(公告)日:2006-11-16

    申请号:US10530483

    申请日:2003-10-09

    IPC分类号: A61K9/20 B27N3/00

    摘要: The invention concerns a method for producing solid galenic formulations which consists in: forming a processable paste comprising a) 50 to 99.4 wt. % of at least one non-thermoplastic carrier, b) 0.5 to 30 wt. % of at least an adjuvant selected among thermoplastic polymers, lipids, sugar alcohols and solubilizing agents, c) 0.1 to 49.5 wt. % of at least one active principle, at a temperature not less than the softening temperature of the adjuvant but rising to at least 70° C.; then in cooling the resulting paste. Said solid galenic formulations quickly disintegrate in an aqueous medium.

    摘要翻译: 本发明涉及一种制备固体盖仑制剂的方法,其中包括:形成可加工的糊剂,其包含a)50至99.4wt。 %的至少一种非热塑性载体,b)0.5〜30wt。 至少选自热塑性聚合物,脂质,糖醇和增溶剂中的佐剂的%,c)0.1至49.5wt。 %的至少一种活性成分,在不低于佐剂的软化温度但升至至少70℃的温度下。 然后冷却所得糊状物。 所述固体盖仑制剂在水性介质中快速崩解。